Robert Dolski - Jan 27, 2022 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc. (CMPI)

Role
Chief Financial Officer
Signature
/s/ Kleem Chaudhary, attorney-in-fact
Stock symbol
CMPI
Transactions as of
Jan 27, 2022
Transactions value $
$0
Form type
4
Date filed
1/31/2022, 03:05 PM
Previous filing
Aug 6, 2021
Next filing
May 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPI Stock Option (Right to Buy) Award $0 +101K $0.00 101K Jan 27, 2022 Common Stock 101K $2.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to such option vest and become exercisable on January 27, 2023 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.